Literature DB >> 27082535

Voriconazole-Susceptible and Voriconazole-Resistant Aspergillus fumigatus Coinfection.

Eva Kolwijck1, Hans van der Hoeven1, Ruud G L de Sévaux1, Jaap ten Oever1, L Lucia Rijstenberg1, Henrich A L van der Lee1, Jan Zoll1, Willem J G Melchers1, Paul E Verweij1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27082535     DOI： 10.1164/rccm.201510-2104LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  15 in total

Review 1.  Clinical implications of globally emerging azole resistance in Aspergillus fumigatus.

Authors:  Jacques F Meis; Anuradha Chowdhary; Johanna L Rhodes; Matthew C Fisher; Paul E Verweij
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-12-05       Impact factor: 6.237

Review 2.  Aspergillus fumigatus morphology and dynamic host interactions.

Authors:  Frank L van de Veerdonk; Mark S Gresnigt; Luigina Romani; Mihai G Netea; Jean-Paul Latgé
Journal:  Nat Rev Microbiol       Date:  2017-09-18       Impact factor: 60.633

3.  Single-Center Evaluation of an Agar-Based Screening for Azole Resistance in Aspergillus fumigatus by Using VIPcheck.

Authors:  J B Buil; H A L van der Lee; A J M M Rijs; J Zoll; J A M F Hovestadt; W J G Melchers; P E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

4.  Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity.

Authors:  Tatiana Y Hargrove; Edward P Garvey; William J Hoekstra; Christopher M Yates; Zdzislaw Wawrzak; Girish Rachakonda; Fernando Villalta; Galina I Lepesheva
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

5.  A Novel Broad Allele-Specific TaqMan Real-Time PCR Method To Detect Triazole-Resistant Strains of Aspergillus fumigatus, Even with a Very Low Percentage of Triazole-Resistant Cells Mixed with Triazole-Susceptible Cells.

Authors:  Qian Wang; Dimitrios P Kontoyiannis; Ruoyu Li; Wei Chen; Dingfang Bu; Wei Liu
Journal:  J Clin Microbiol       Date:  2019-08-26       Impact factor: 5.948

6.  In Vivo Efficacy of Liposomal Amphotericin B against Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates in Two Different Immunosuppression Models of Invasive Aspergillosis.

Authors:  Seyedmojtaba Seyedmousavi; Johan W Mouton; Willem J G Melchers; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

Review 7.  Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.

Authors:  Anna Dudakova; Birgit Spiess; Marut Tangwattanachuleeporn; Christoph Sasse; Dieter Buchheidt; Michael Weig; Uwe Groß; Oliver Bader
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

8.  A Novel Combination of CYP51A Mutations Confers Pan-Azole Resistance in Aspergillus fumigatus.

Authors:  Daiana Macedo; Tomás Brito Devoto; Santiago Pola; Jorge L Finquelievich; María L Cuestas; Guillermo Garcia-Effron
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

9.  A Novel Environmental Azole Resistance Mutation in Aspergillus fumigatus and a Possible Role of Sexual Reproduction in Its Emergence.

Authors:  Jianhua Zhang; Eveline Snelders; Bas J Zwaan; Sijmen E Schoustra; Jacques F Meis; Karin van Dijk; Ferry Hagen; Martha T van der Beek; Greetje A Kampinga; Jan Zoll; Willem J G Melchers; Paul E Verweij; Alfons J M Debets
Journal:  MBio       Date:  2017-06-27       Impact factor: 7.867

10.  Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.

Authors:  Sang Taek Heo; Alexander M Tatara; Cristina Jiménez-Ortigosa; Ying Jiang; Russell E Lewis; Jeffrey Tarrand; Frank Tverdek; Nathaniel D Albert; Paul E Verweij; Jacques F Meis; Antonios G Mikos; David S Perlin; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.